Ann Marie Kaukonen

3.4k total citations
35 papers, 2.8k citations indexed

About

Ann Marie Kaukonen is a scholar working on Oncology, Pharmaceutical Science and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ann Marie Kaukonen has authored 35 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pharmaceutical Science and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ann Marie Kaukonen's work include Drug Transport and Resistance Mechanisms (12 papers), Drug Solubulity and Delivery Systems (7 papers) and Pharmaceutical studies and practices (7 papers). Ann Marie Kaukonen is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Drug Solubulity and Delivery Systems (7 papers) and Pharmaceutical studies and practices (7 papers). Ann Marie Kaukonen collaborates with scholars based in Finland, Australia and Netherlands. Ann Marie Kaukonen's co-authors include Jouni Hirvonen, Christopher J. H. Porter, William N. Charman, Jarno Salonen, Vesa‐Pekka Lehto, Ben J. Boyd, L. Laitinen, Jaani Tuura, T. Heikkilä and Glenn A. Edwards and has published in prestigious journals such as Analytical Chemistry, Journal of Controlled Release and Journal of Chromatography A.

In The Last Decade

Ann Marie Kaukonen

35 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Marie Kaukonen Finland	23	1.1k	1.0k	539	477	413	35	2.8k
Roger A. Rajewski United States	25	712 0.7×	1.6k 1.6×	640 1.2×	960 2.0×	249 0.6×	49	3.5k
Gary G. Liversidge United States	14	976 0.9×	2.5k 2.5×	503 0.9×	696 1.5×	717 1.7×	31	3.8k
Zhonggui He China	32	513 0.5×	1.4k 1.4×	615 1.1×	1.1k 2.2×	1.0k 2.5×	133	3.5k
Elaine Merisko‐Liversidge United States	11	618 0.6×	1.5k 1.5×	310 0.6×	486 1.0×	551 1.3×	13	2.4k
Marzia Cirri Italy	40	605 0.6×	2.4k 2.4×	224 0.4×	569 1.2×	424 1.0×	86	3.3k
Hywel D. Williams Australia	28	1.0k 0.9×	2.3k 2.3×	188 0.3×	612 1.3×	274 0.7×	42	3.6k
Shigeru Itai Japan	24	520 0.5×	1.1k 1.1×	259 0.5×	472 1.0×	276 0.7×	120	2.3k
Marcela R. Longhi Argentina	28	655 0.6×	1.1k 1.1×	206 0.4×	487 1.0×	281 0.7×	109	2.3k
Bernard Van Eerdenbrugh Belgium	25	1.3k 1.2×	2.2k 2.2×	328 0.6×	551 1.2×	446 1.1×	35	3.3k
Toshikiro Kimura Japan	30	474 0.4×	1.7k 1.7×	291 0.5×	951 2.0×	647 1.6×	111	3.6k

Countries citing papers authored by Ann Marie Kaukonen

Since Specialization

Citations

This map shows the geographic impact of Ann Marie Kaukonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Marie Kaukonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Marie Kaukonen more than expected).

Fields of papers citing papers by Ann Marie Kaukonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Marie Kaukonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Marie Kaukonen. The network helps show where Ann Marie Kaukonen may publish in the future.

Co-authorship network of co-authors of Ann Marie Kaukonen

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Marie Kaukonen. A scholar is included among the top collaborators of Ann Marie Kaukonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Marie Kaukonen. Ann Marie Kaukonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Airaksinen, Marja, et al.. (2010). Evolution of paediatric off‐label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994–2007. British Journal of Clinical Pharmacology. 71(6). 929–935. 10 indexed citations

Tolonen, Ari, et al.. (2009). Caco-2 cell monolayers as a tool to study simultaneous phase II metabolism and metabolite efflux of indomethacin, paracetamol and 1-naphthol. International Journal of Pharmaceutics. 383(1-2). 24–29. 34 indexed citations

Zhang, Hongbo, et al.. (2008). The Expression of Most UDP-Glucuronosyltransferases (UGTs) Is Increased Significantly during Caco-2 Cell Differentiation, whereas UGT1A6 Is Highly Expressed Also in Undifferentiated Cells. Drug Metabolism and Disposition. 36(11). 2331–2336. 20 indexed citations

Kaukonen, Ann Marie, et al.. (2008). Transport evaluation of salicylic acid and structurally related compounds across Caco-2 cell monolayers and artificial PAMPA membranes. European Journal of Pharmaceutics and Biopharmaceutics. 70(2). 531–538. 10 indexed citations

Andersson, Mats R., et al.. (2007). Cell–polymer interactions of fluorescent polystyrene latex particles coated with thermosensitive poly(N-isopropylacrylamide) and poly(N-vinylcaprolactam) or grafted with poly(ethylene oxide)-macromonomer. International Journal of Pharmaceutics. 343(1-2). 238–246. 37 indexed citations

Heikkilä, T., Jarno Salonen, Jaani Tuura, et al.. (2007). Evaluation of Mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 Materials as API Carriers for Oral Drug Delivery. Drug Delivery. 14(6). 337–347. 157 indexed citations

Limnell, Tarja, Joakim Riikonen, Jarno Salonen, et al.. (2007). Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles. International Journal of Pharmaceutics. 343(1-2). 141–147. 77 indexed citations

Laitinen, Leena, Kati‐Sisko Vellonen, Hanna Kortejärvi, et al.. (2007). Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines. European Journal of Pharmaceutics and Biopharmaceutics. 67(2). 548–554. 39 indexed citations

Hakala, Kati, et al.. (2006). Evaluation of cocktail approach to standardise Caco-2 permeability experiments. European Journal of Pharmaceutics and Biopharmaceutics. 64(3). 379–387. 32 indexed citations

10.

Murtomäki, Lasse, et al.. (2006). The Effect of Valence on the Ion-Exchange Process: Theoretical and Experimental Aspects on Compound Binding/Release. Journal of Pharmaceutical Sciences. 96(1). 117–131. 10 indexed citations

11.

Kaukonen, Ann Marie, Leena Laitinen, Jarno Salonen, et al.. (2006). Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles. European Journal of Pharmaceutics and Biopharmaceutics. 66(3). 348–356. 62 indexed citations

12.

Laitinen, Leena, et al.. (2006). Anthranoid laxatives influence the absorption of poorly permeable drugs in human intestinal cell culture model (Caco-2). European Journal of Pharmaceutics and Biopharmaceutics. 66(1). 135–145. 25 indexed citations

13.

Kaukonen, Ann Marie, Ben J. Boyd, Christopher J. H. Porter, & William N. Charman. (2004). Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations. Pharmaceutical Research. 21(2). 245–253. 181 indexed citations

14.

Porter, Christopher J. H., et al.. (2004). Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine. Journal of Pharmaceutical Sciences. 93(5). 1110–1121. 185 indexed citations

15.

Kaukonen, Ann Marie, Ben J. Boyd, William N. Charman, & Christopher J. H. Porter. (2004). Drug Solubilization Behavior During in Vitro Digestion of Suspension Formulations of Poorly Water-Soluble Drugs in Triglyceride Lipids. Pharmaceutical Research. 21(2). 254–260. 102 indexed citations

16.

Porter, Christopher J. H., Ann Marie Kaukonen, Ben J. Boyd, Glenn A. Edwards, & William N. Charman. (2004). Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation. Pharmaceutical Research. 21(8). 1405–1412. 209 indexed citations

17.

Kaukonen, Ann Marie, et al.. (2003). Rate and extent of ion-exchange process: the effect of physico-chemical characteristics of salicylate anions. Journal of Controlled Release. 91(3). 449–463. 23 indexed citations

18.

Kaukonen, Ann Marie, et al.. (2003). Development of indomethacin Carbopol ETD 2001 gels and the influence of storage time and temperature on their stability.. PubMed. 58(2). 130–5. 4 indexed citations

19.

Kaukonen, Ann Marie, Pia Vuorela, Heikki Vuorela, & Jukka‐Pekka Mannermaa. (1998). High-performance liquid chromatography methods for the separation and quantitation of spironolactone and its degradation products in aqueous formulations and of its metabolites in rat serum. Journal of Chromatography A. 797(1-2). 271–281. 23 indexed citations

20.

Kaukonen, Ann Marie, Ilkka Kilpeläinen, & Jukka‐Pekka Mannermaa. (1997). Water-soluble β-cyclodextrins in paediatric oral solutions of spironolactone: solubilization and stability of spironolactone in solutions of β-cyclodextrin derivatives. International Journal of Pharmaceutics. 159(2). 159–170. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact